Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry
Author(s) -
Livio Pagano,
Morena Caira,
Anna Candoni,
Franco Aversa,
Carlo Castagnola,
Cecilia Caramatti,
Chiara Cattaneo,
Mario Delia,
Maria Rosaria De Paolis,
Roberta Di Blasi,
Luigi Di Caprio,
Rosa Fanci,
Mariagrazia Garzia,
B. Martino,
Lorella Melillo,
Maria Enza Mitra,
Gianpaolo Nadali,
Annamaria Nosari,
Marco Picardi,
Leonardo Potenza,
Prassede Salutari,
Enrico Maria Trecarichi,
Mario Tumbarello,
Luisa Verga,
Nicola Vianelli,
Alessandro Busca
Publication year - 2012
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cis773
Subject(s) - posaconazole , itraconazole , medicine , fluconazole , incidence (geometry) , antifungal , surgery , dermatology , physics , optics
To analyze the efficacy of antifungal prophylaxis (AFP) with posaconazole and itraconazole in a real-life setting of patients with acute myeloid leukemia (AML) during the first induction of remission.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom